These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 349283)

  • 1. [How potent are the cortisone ointments?].
    Agrup G; Lassus A; Lidén S; Osmundsen PE; Rajka G; Søndergaard J
    Lakartidningen; 1978 May; 75(19):1924-5. PubMed ID: 349283
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation of the vasoconstriction assay and clinical activity in psoriasis.
    Cornell RC; Stoughton RB
    Arch Dermatol; 1985 Jan; 121(1):63-7. PubMed ID: 3881088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [How potent are steroid ointments?].
    Agrup G; Lassus A; Lidén S; Osmundsen PE; Rajka G; Søndergaard J
    Ugeskr Laeger; 1978 Jun; 140(26):1565-6. PubMed ID: 356374
    [No Abstract]   [Full Text] [Related]  

  • 4. [Results of a clinical comparative double blind test between the 2 topical corticoides, 17-desoxymethasone and betamethasone, in the treatment of psoriasis].
    Piñól Aguade J; Martino ML
    Actas Dermosifiliogr; 1977; 68(7-8):401-8. PubMed ID: 337764
    [No Abstract]   [Full Text] [Related]  

  • 5. [Budesonide--a potent nonfluorinated derivative of the new generation of topical steroids].
    Salde L; Schröpl F
    Z Hautkr; 1982 Dec; 57(23):1745-54. PubMed ID: 6761989
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of betamethasone dipropionate (0.05%) and betamethasone valerate (0.1%) ointments in psoriasis and other dermatoses--a multicentric double-blind clinical study.
    Sharma SD
    Indian J Dermatol; 1986; 31(2-3):34-7. PubMed ID: 3327820
    [No Abstract]   [Full Text] [Related]  

  • 7. [Non-halogenated glucocorticoids in the treatment of psoriasis].
    Tølløfsrud A; Malmsten LA
    Tidsskr Nor Laegeforen; 1982 Mar; 102(9-10):560-1. PubMed ID: 6760456
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical double blind test with flupamesone and halcinonide].
    Ferrandiz Arjonilla L
    Rev Clin Esp; 1978 Jun; 149(5):495-7. PubMed ID: 358318
    [No Abstract]   [Full Text] [Related]  

  • 9. Double-blind comparison of halcinonide and betamethasone valerate. Use with occlusive dressings in psoriasis treatment.
    Clark RF; Clement ER
    Arch Dermatol; 1975 Jun; 111(6):731-3. PubMed ID: 1094960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procedures for the clinical investigation of a topical corticosteroid.
    Craps L; Ferner U
    Acta Derm Venereol Suppl (Stockh); 1973; 53():13-23. PubMed ID: 4585161
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diprosone cream: its value in daily dermatologic practice].
    Lille Med; 1975 Jan; 20(1):61-3. PubMed ID: 1134174
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of psoriasis with flupamesone and ultraviolet light].
    Gajate Geanini A
    Rev Clin Esp; 1977 Feb; 144(4):287-91. PubMed ID: 847264
    [No Abstract]   [Full Text] [Related]  

  • 13. Topical Corticosteroids International Symposium, Venice, May 1972. Introductory remarks.
    Craps L
    Acta Derm Venereol Suppl (Stockh); 1973; 53():9-11. PubMed ID: 4585162
    [No Abstract]   [Full Text] [Related]  

  • 14. A double-blind comparison of fluocinonide and betamethasone valerate ointments.
    McCuistion CH; Schoch EP; Warthan TL
    Curr Ther Res Clin Exp; 1973 Feb; 15(2):44-7. PubMed ID: 4632505
    [No Abstract]   [Full Text] [Related]  

  • 15. Risks of unoccluded topical steroids in clinical trials.
    Akers WA
    Arch Dermatol; 1980 Jul; 116(7):786-8. PubMed ID: 6994659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
    Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ
    J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic value of theophylline in psoriasis].
    Texier L; Gauthier MO; Gauthier Y; Tamisier JM; Delaunay MM
    Ann Dermatol Syphiligr (Paris); 1976; 103(5-6):645-7. PubMed ID: 797302
    [No Abstract]   [Full Text] [Related]  

  • 18. Augmented betamethasone: efficacy in psoriasis with different dosing frequencies.
    Singh S
    Arch Dermatol; 1996 Dec; 132(12):1525-6. PubMed ID: 8961896
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of steroids in topical treatment of psoriasis.
    Groth O; Juhlin L; Michaëlsson G; Ohman S
    Acta Derm Venereol; 1967; 47(4):216-21. PubMed ID: 4166056
    [No Abstract]   [Full Text] [Related]  

  • 20. [Reducing the dosage by new technology].
    Steinhorst M
    Hautarzt; 2001 Jan; 52(1):p following 90 (91). PubMed ID: 11220248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.